Palisade Bio, Inc. (PALI)
NASDAQ: PALI · Real-Time Price · USD
2.340
+0.170 (7.83%)
Nov 20, 2025, 4:00 PM EST - Market closed

Palisade Bio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202018 - 2019
Period Ending
Nov '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
34955818-
Upgrade
Market Cap Growth
10264.85%-16.56%-31.77%-54.57%--
Upgrade
Enterprise Value
344-3-9-54-
Upgrade
Last Close Price
2.341.658.8578.00975.00-
Upgrade
PS Ratio
--21.88---
Upgrade
PB Ratio
6.650.610.480.642.40-
Upgrade
P/TBV Ratio
108.620.610.480.642.40-
Upgrade
Debt / Equity Ratio
0.070.020.030.030.03-0.20
Upgrade
Asset Turnover
--0.02---
Upgrade
Quick Ratio
1.513.054.874.594.260.10
Upgrade
Current Ratio
1.963.245.154.894.610.11
Upgrade
Return on Equity (ROE)
-228.64%-153.56%-103.40%-143.72%-20012.03%-
Upgrade
Return on Assets (ROA)
-87.81%-74.50%-53.85%-67.69%-94.46%-161.72%
Upgrade
Return on Capital (ROIC)
-137.86%-96.02%-65.36%-93.60%-777.90%-
Upgrade
Return on Capital Employed (ROCE)
-327.80%-194.40%-112.00%-120.10%-117.20%183.60%
Upgrade
Earnings Yield
-3.22%-316.35%-224.87%-177.89%-150.84%-
Upgrade
FCF Yield
-2.89%-267.16%-203.61%-166.78%-83.72%-
Upgrade
Buyback Yield / Dilution
-367.35%-210.62%-677.03%-370.85%--
Upgrade
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q